Breast Cancer Management Market

Global Breast Cancer Management Market Size, Trends & Analysis - Forecasts to 2028 By Product (Diagnostics [Platform Based Products {Next Generation Sequencing, Microarrays, PCR}, Instrument Based Products {Imaging, Biopsy}], Therapeutics [Targeted Therapy, Hormonal Therapy, Chemotherapy, Immunotherapy]), By Application (Screening, Diagnostic & Predictive, Prognostic, Research & Academics, Cancer Treatment, Others), By End-Use (Hospitals & Clinics, Diagnostic Centers & Medical Laboratories, Others), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis

Category Healthcare

Format

This report was recently updated on April 19 2024 with the latest and most recent market numbers

Global Breast Cancer Management Market Size

The global breast cancer management market is projected to grow at a CAGR of 12.1% from 2023 to 2028 and accounted for a market revenue of USD 28.2 billion in 2022.

Breast cancer is one of the most commonly occurring cancers and management of breast cancer has been the top priority for the past few years. Breast cancer is one of the most common cancers worldwide and an efficient, accurate treatment and management plan is required to improve the diagnostics and post-care management is extremely crucial.

In 2020, according to the International Agency for Research on Cancer – World Health Organization, there was an increase in breast cancer by 11% globally. Thus, the occurrence and mortality rate of the disease drives the global breast cancer management market.

There are many advancements in the cancer biology sector, as well as a massive increase in R&D investments for various screening, diagnostic, and other research purposes. Many breakthroughs in the field of science and treatment plants are another reason propelling the market.

For instance, advanced therapies such as targeted therapies and immunotherapies are substantially growing. Immunotherapy is the use of medications to boost a person's immune system so that it can more effectively recognize and destroy cancer cells. Some immunotherapy drugs, such as monoclonal antibodies, work in more than one way to control cancer cells and may also be considered targeted therapy because they inhibit the growth of a specific protein on the cancer cell. This will boost the market during the forecast period.

Furthermore, many companies are advancing their research for drug development for breast cancer. For example, Sanofi, one of the leading companies in the field of cancer therapeutics is conducting research and development, especially for oral treatments for metastatic breast cancer. Such trends will further propel the breast cancer management market.

global breast cancer management market

Global Breast Cancer Management Market: By End-Use

The hospitals & clinics segment is expected to witness the largest share in the global breast cancer management market during the forecast period of 2023-2028. Patients depend highly on the hospitals for diagnosis, treatment, drug therapies as well as other advanced therapies during the treatment. Some cancer patients will only receive one treatment. Most people, however, receive a combination of treatments, such as surgery combined with chemotherapy and/or radiation therapy. Immunotherapy, targeted therapy, and hormone therapy are all options. All of these are available in hospitals to assist patients. Many clinical trials for advanced technology and treatment plans are also ongoing. This drives the hospital segment significantly during the period.

The diagnostic centers and medical laboratories segment is expected to grow the fastest during 2023-2028. The diagnostic centers help with breast ultrasound, diagnostic mammograms, biopsies, and breast magnetic resonance imaging. These are extremely necessary during the several stages of cancer treatment. Furthermore, during the pandemic, when the hospitals were only open for COVID-19 patients, the healthcare industry relied heavily on medical laboratories and diagnostic centers, especially for cancer for timely reports for better management of cancer amongst patients.

Global Breast Cancer Management Market: By Application

The screening segment is expected to witness the largest share in the global breast cancer management market during the forecast period of 2023-2028. Many programs for cancer screening especially by local and regional governments are boosting the segment. As per an NCBI report, breast cancer screening programs help significantly in early detection, optimal treatment plans for a better lifestyle, preventing other risk factors, and lowering the morbidity rate. Thus, due to such advantages, screening for cancer has increased rapidly and will further grow during the forecast period.

The diagnostic and predictive analysis segment is expected to grow the fastest during 2023-2028. Machine learning-based predictive models for breast cancer diagnosis promise earlier detection techniques. Accurate diagnosis is a difficult task for physicians. To provide appropriate treatment, an automatic prediction system that diagnoses the patient is required. As a result, specialized technology and expertise are required to combat this issue.

Global Breast Cancer Management Market: By Product

The diagnostics segment is expected to witness the largest share in the global breast cancer management market during the forecast period of 2023-2028. This segment includes several platform and instrument-based products. For instance, the term next-generation sequencing (NGS) does not refer to a specific breast cancer test. Instead, it refers to a class of tests that look for all genomic mutations in the genes of a tumor. It includes comprehensive genomic profiling and broad molecular profiling. The goal of NGS for people with metastatic breast cancer is to identify specific mutations in their tumor and then target those mutations with an approved therapy or a therapy in clinical trials.

Instrument-based products like imaging and biopsy are necessary for the prediction of cancer. Post an imaging test like a mammogram, biopsies like fine needle aspiration, core needle biopsy, and surgical biopsy are needed. Due to all the advantages, this segment will further grow rapidly.

The therapeutics segment is expected to grow the fastest during 2023-2028. Therapies such as targeted, hormonal, chemotherapy, and immunotherapy are advancing the therapeutics segment during the forecast period. Targeted therapy is being adopted massively in developed as well as emerging countries. With new product launches, drug development would further accelerate the growth of targeted therapy in the therapeutics segment.

asia pacific breast cancer management market

Global Breast Cancer Management Market: By Region

The North America segment is expected to witness the largest share in the global breast cancer management market during the forecast period of 2023-2028. The North American region is home to prominent companies in the market. This helps with new product launches, advanced technologies, and clinical trials between companies and research institutes.

Further, in the United States alone, there is a rise in cases of invasive breast cancer among women. According to the American Cancer Society, in 2020, there were more than 200, 000 cases of breast cancer. This strong prevalence boosts the research for more advanced technologies and therapeutics.

Asia-Pacific is expected to grow the fastest during 2023-2028. Countries in the Asia-Pacific region are advancing their healthcare sectors significantly. This includes constant drug development, strong infrastructure, as well as a surge in healthcare expenditure by respective governments and companies. There is also significant rise in population in India and China and this further propels the breast cancer management market.

There is also substantial growth due to investments in research and development, especially in cancer research. This competitive landscape helps in the growth rate of the global breast cancer management market. Furthermore, renowned companies are expanding their business in Europe for treatments and research therapies.

The market is also expanding in Latin America, the Middle East, and Africa region. With the presence of prominent companies in the region, good infrastructure for hospitals, and treatments, and a rise in healthcare expenditure, the regions are expected to have significant growth during the forecast period.

Global Breast Cancer Management Market Share and Competitor Analysis

Hologic Inc., Genomic Health, BD Inc., Danaher, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., Welch Allyn, Qiagen, Argon Medical Devices, and Thermo Fisher Scientific among others, are some of the key players in the breast cancer management market.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1 Research Methodology

1.1 Research Assumptions

1.2 Research Methodology

1.2.1 Estimates and Forecast Timeline

1.3 Information Procurement

1.3.1 Purchased Database

1.3.2 GME’s Internal Database

1.3.3 Primary Research

1.3.4 Secondary Sources & Third-Party Perspectives

1.3.4.1 Company Information Sources: Annual Reports, Investor Presentation, Press Release, SEC Filing, Company Blogs & Website

1.3.4.2 Secondary Data Sources: World Health Organization

1.4 Information or Data Analysis

1.4.1 Data Analysis Models

1.5 Market End-User & Data Visualization

1.6 Data Validation & Publishing

1.7 Market Model

1.7.1 Model Details

1.7.1.1 Top-Down Approach

1.7.1.2 Bottom-Up Approach

1.8 Market Segmentation & Scope

1.9 Market Definition

Chapter 2 Executive Summary

2.1. Global Market Outlook

2.2 Application Outlook

2.3 Product Outlook

2.4 End-User Outlook

2.5 Regional Outlook

Chapter 3 Global Breast Cancer Management Market Trend Analysis

3.1. Market Introduction

3.2 Penetration & Growth Prospect Mapping

3.3 Impact of COVID-19 on the Breast Cancer Management Market

3.4 Metric Data on Healthcare Industry

3.5 Market Dynamic

3.5.1 Market Driver Analysis

3.5.2 Market Restraint Analysis

3.5.3 Industry Challenges

3.5.4 Industry Opportunities

3.6 Porter’s Five Analysis

3.6.1 Threat of New Entrants

3.6.2 Threat of New Substitutes

3.6.3 Bargaining Power of Buyers/Suppliers

3.6.4 Intensity of Competitive Rivalry

3.7 Market Entry Strategies

Chapter 4 Breast Cancer Management Market: Application Trend Analysis

4.1 Application: Historic Data vs. Forecast Data Analysis, 2022 vs. 2028

4.2 Screening

4.2.1 Market Estimates & Forecast Analysis of Screening Segment, By Region, 2019-2028 (USD Billion)

4.3 Diagnostic & Predictive

4.3.1 Market Estimates & Forecast Analysis of Diagnostic & Predictive Markets Segment, By Region, 2019-2028 (USD Billion)

4.4 Prognostic

4.4.1 Market Estimates & Forecast Analysis of Prognostic Markets Segment, By Region, 2019-2028 (USD Billion)

4.5 Research & Academics

4.5.1 Market Estimates & Forecast Analysis of Research & Academics Markets Segment, By Region, 2019-2028 (USD Billion)

4.6 Cancer Treatment

4.6.1 Market Estimates & Forecast Analysis of Cancer Treatment Markets Segment, By Region, 2019-2028 (USD Billion)

Chapter 5 Breast Cancer Management Market: Product Trend Analysis

5.1 Product: Historic Data vs. Forecast Data Analysis, 2022 vs. 2028

5.2 Diagnostics

5.2.1 Market Estimates & Forecast Analysis of Diagnostics Segment, By Region, 2019-2028 (USD Billion)

5.2.1 Platform Based Products

5.2.1.1 Market Estimates & Forecast Analysis of Platform Based Segments Segment, By Region, 2019-2028 (USD Billion)

5.2.2 Instrument Based Products

5.2.2.1 Market Estimates & Forecast Analysis of Instrument Based Products Segment, By Region, 2019-2028 (USD Billion)

5.3 Therapeutics

5.3.1 Market Estimates & Forecast Analysis of Therapeutics Segment, By Region, 2019-2028 (USD Billion)

5.3.1 Targeted Therapy

5.3.1.1 Market Estimates & Forecast Analysis of Targeted Therapy Segment, By Region, 2019-2028 (USD Billion)

5.3.2 Hormonal Therapy

5.3.2.1 Market Estimates & Forecast Analysis of Hormonal Therapy Segment, By Region, 2019-2028 (USD Billion)

5.3.3 Chemotherapy

5.3.3.1 Market Estimates & Forecast Analysis of Chemotherapy Segment, By Region, 2019-2028 (USD Billion)

5.3.4 Immunotherapy

5.3.4.1 Market Estimates & Forecast Analysis of Immunotherapy Segment, By Region, 2019-2028 (USD Billion)

Chapter 6 Breast Cancer Management Market: End-User Trend Analysis

6.1 End-User: Historic Data vs. Forecast Data Analysis, 2022 vs. 2028

6.2 Hospitals & Clinics

6.2.1 Market Estimates & Forecast Analysis of Hospitals & Clinics Segment, By Region, 2019-2028 (USD Billion)

6.3 Diagnostic Centers & Medical Laboratories

6.3.1 Market Estimates & Forecast Analysis of Governance, Diagnostic Centers & Medical Laboratories Segment, By Region, 2019-2028 (USD Billion)

Chapter 7 Breast Cancer Management Market, By Region

7.1 Regional Outlook

7.2 North America

7.2.1 Market Estimates & Forecast Analysis, By Country 2019-2028(USD Billion)

7.2.2 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)

7.2.3 Market Estimates & Forecast Analysis, By Product, 2019-2028(USD Billion)

7.2.4 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)

7.2.5 U.S.

7.2.5.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)

7.2.5.2 Market Estimates & Forecast Analysis, By Product, 2019-2028(USD Billion)

7.2.5.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)

7.2.6 Canada

7.2.6.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)

7.2.6.2 Market Estimates & Forecast Analysis, By Product, 2019-2028(USD Billion)

7.2.6.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)

7.2.7 Mexico

7.2.7.1 Market Estimates & Forecast Analysis, By Application, 2019-2028 (USD Billion)

7.2.7.2 Market Estimates & Forecast Analysis, By Product, 2019-2028 (USD Billion)

7.2.7.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028 (USD Billion)

8.3 Europe

8.3.1 Market Estimates & Forecast Analysis, By Country 2019-2028(USD Billion)

8.3.2 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)

8.3.3 Market Estimates & Forecast Analysis, By Product, 2019-2028(USD Billion)

8.3.4 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)

8.3.5 Germany

8.3.5.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)

8.3.5.2 Market Estimates & Forecast Analysis, By Product, 2019-2028(USD Billion)

8.3.5.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)

8.3.6 UK

8.3.6.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)

8.3.6.2 Market Estimates & Forecast Analysis, By Product, 2019-2028(USD Billion)

8.3.6.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)

8.3.7 France

8.3.7.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)

8.3.7.2 Market Estimates & Forecast Analysis, By Product, 2019-2028(USD Billion)

8.3.7.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)

8.3.8 Russia

8.3.8.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)

8.3.8.2 Market Estimates & Forecast Analysis, By Product, 2019-2028(USD Billion)

8.3.7.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)

8.3.9 Italy

8.3.9.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)

8.3.9.2 Market Estimates & Forecast Analysis, By Product, 2019-2028(USD Billion)

8.3.9.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)

8.3.10 Spain

8.3.10.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)

8.3.10.2 Market Estimates & Forecast Analysis, By Product, 2019-2028(USD Billion)

8.3.10.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)

8.3.11 Rest of Europe

8.3.11.1 Market Estimates & Forecast Analysis, By Application, 2019-2028 (USD Billion)

8.3.11.2 Market Estimates & Forecast Analysis, By Product, 2019-2028 (USD Billion)

8.3.11.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028 (USD Billion)

8.4 Asia Pacific

8.4.1 Market Estimates & Forecast Analysis, By Country 2019-2028(USD Billion)

8.4.2 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)

8.4.3 Market Estimates & Forecast Analysis, By Product, 2019-2028(USD Billion)

8.4.4 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)

8.4.5 China

8.4.5.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)

8.4.5.2 Market Estimates & Forecast Analysis, By Product, 2019-2028(USD Billion)

8.4.5.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)

8.4.6 India

8.4.6.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)

8.4.6.2 Market Estimates & Forecast Analysis, By Product, 2019-2028(USD Billion)

8.4.6.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)

8.4.8 Japan

8.4.8.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)

8.4.8.2 Market Estimates & Forecast Analysis, By Product, 2019-2028(USD Billion)

8.4.8.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)

8.4.8 Australia

8.4.8.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)

8.4.8.2 Market Estimates & Forecast Analysis, By Product, 2019-2028(USD Billion)

8.4.8.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)

8.4.9 South Korea

8.4.9.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)

8.4.9.2 Market Estimates & Forecast Analysis, By Product, 2019-2028(USD Billion)

8.4.9.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)

8.4.10 Rest of Asia Pacific

8.4.10.1 Market Estimates & Forecast Analysis, By Application, 2019-2028 (USD Billion)

8.4.10.2 Market Estimates & Forecast Analysis, By Product, 2019-2028 (USD Billion)

8.4.10.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028 (USD Billion)

8.5 Central & South America

8.5.1 Market Estimates & Forecast Analysis, By Country 2019-2028(USD Billion)

8.5.2 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)

8.5.3 Market Estimates & Forecast Analysis, By Product, 2019-2028(USD Billion)

8.5.4 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)

8.5.5 Brazil

8.5.5.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)

8.5.5.2 Market Estimates & Forecast Analysis, By Product, 2019-2028(USD Billion)

8.5.5.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)

8.5.6 Rest of Central & South America

8.5.6.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)

8.5.6.2 Market Estimates & Forecast Analysis, By Product, 2019-2028(USD Billion)

8.5.6.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)

8.6 Middle East & Africa

8.6.1 Market Estimates & Forecast Analysis, By Country 2019-2028(USD Billion)

8.6.2 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)

8.6.3 Market Estimates & Forecast Analysis, By Product, 2019-2028(USD Billion)

8.6.4 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)

8.6.5 Saudi Arabia

8.6.5.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)

8.6.5.2 Market Estimates & Forecast Analysis, By Product, 2019-2028(USD Billion)

8.6.5.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)

8.6.6 United Arab Emirates

8.6.6.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)

8.6.6.2 Market Estimates & Forecast Analysis, By Product, 2019-2028(USD Billion)

8.6.6.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)

8.6.7 South Africa

8.6.7.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)

8.6.7.2 Market Estimates & Forecast Analysis, By Product, 2019-2028(USD Billion)

8.6.7.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)

8.6.8 Rest of Middle East & Africa

8.6.8.1 Market Estimates & Forecast Analysis, By Application, 2019-2028 (USD Billion)

8.6.8.2 Market Estimates & Forecast Analysis, By Product, 2019-2028 (USD Billion)

8.6.8.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028 (USD Billion)

Chapter 9 Competitive Analysis

9.1 Key Global Players, Recent Developments & their Impact on the Industry

9.2 Four Quadrant Competitor Positioning Matrix

9.2.1 Key Innovators

9.2.2 Market Leaders

9.2.3 Emerging Players

9.2.4 Market Challengers

9.3 Vendor Landscape Analysis

9.4 End-User Landscape Analysis

9.5 Company Market Share Analysis, 2022

Chapter 10 Company Profile Analysis

10.1 Competitive Analysis, 2022

10.2 Hologic Inc.

10.2.1 Company Overview

10.2.2 Financial Analysis

10.2.3 Strategic Positioning

10.2.4 Info Graphic Analysis

10.3 Genomic Health

10.3.1 Company Overview

10.3.2 Financial Analysis

10.3.3 Strategic Positioning

10.3.4 Info Graphic Analysis

10.4 BD Inc.

10.4.1 Company Overview

10.4.2 Financial Analysis

10.4.3 Strategic Positioning

10.4.4 Info Graphic Analysis

10.5 Danaher

10.5.1 Company Overview

10.5.2 Financial Analysis

10.5.3 Strategic Positioning

10.5.4 Info Graphic Analysis

10.6 Koninklijke Philips N.V.

10.6.1 Company Overview

10.6.2 Financial Analysis

10.6.3 Strategic Positioning

10.6.4 Info Graphic Analysis

10.7 F. Hoffmann-La Roche Ltd.

10.7.1 Company Overview

10.7.2 Financial Analysis

10.7.3 Strategic Positioning

10.7.4 Info Graphic Analysis

10.8 Welch Allyn

10.8.1 Company Overview

10.8.2 Financial Analysis

10.8.3 Strategic Positioning

10.8.4 Info Graphic Analysis

10.9 Qiagen

10.9.1 Company Overview

10.9.2 Financial Analysis

10.9.3 Strategic Positioning

10.9.4 Info Graphic Analysis

10.10 Argon Medical Devices

10.10.1 Company Overview

10.10.2 Financial Analysis

10.10.3 Strategic Positioning

10.10.4 Info Graphic Analysis

10.11 Thermo Fisher Scientific

10.11.1 Company Overview

10.11.2 Financial Analysis

10.11.3 Strategic Positioning

10.11.4 Info Graphic Analysis

10.12 Other Players

10.12.1 Company Overview

10.12.2 Financial Analysis

10.12.3 Strategic Positioning

10.12.4 Info Graphic Analysis

List of Tables

1 Technological Advancements In the Breast Cancer Management Market

2 Global Breast Cancer Management Market: Key Market Drivers

3 Global Breast Cancer Management Market: Key Market Challenges

4 Global Breast Cancer Management Market: Key Market Opportunities

5 Global Breast Cancer Management Market: Key Market Restraints

6 Global Breast Cancer Management Market Estimates & Forecast Analysis, 2019-2028 (USD Billion)

7 Global Breast Cancer Management Market, By Application, 2019-2028 (USD Billion)

8 Diagnostic & Predictive: Global Breast Cancer Management Market, By Region, 2019-2028 (USD Billion)

9 Screening: Global Breast Cancer Management Market, By Region, 2019-2028 (USD Billion)

10 Prognostic: Global Breast Cancer Management Market, By Region, 2019-2028 (USD Billion)

11 Research & Academics: Global Breast Cancer Management Market, By Region, 2019-2028 (USD Billion)

12 Cancer Treatment: Global Breast Cancer Management Market, By Region, 2019-2028 (USD Billion)

13 Global Breast Cancer Management Market, By Product, 2019-2028 (USD Billion)

14 Diagnostics: Global Breast Cancer Management Market, By Region, 2019-2028 (USD Billion)

15 Therapeutics: Global Breast Cancer Management Market, By Region, 2019-2028 (USD Billion)

16 Global Breast Cancer Management Market, By End-User, 2019-2028 (USD Billion)

17 Hospitals & Clinics: Global Breast Cancer Management Market, By Region, 2019-2028 (USD Billion)

18 Diagnostic Centers & Medical Laboratories: Global Breast Cancer Management Market, By Region, 2019-2028 (USD Billion)

19 Regional Analysis: Global Breast Cancer Management Market, By Region, 2019-2028 (USD Billion)

20 North America: Breast Cancer Management Market, By Application, 2019-2028 (USD Billion)

21 North America: Breast Cancer Management Market, By Product, 2019-2028 (USD Billion)

22 North America: Breast Cancer Management Market, By End-User, 2019-2028 (USD Billion)

23 North America: Breast Cancer Management Market, By Country, 2019-2028 (USD Billion)

24 U.S: Breast Cancer Management Market, By Application, 2019-2028 (USD Billion)

25 U.S: Breast Cancer Management Market, By Product, 2019-2028 (USD Billion)

26 U.S: Breast Cancer Management Market, By End-User, 2019-2028 (USD Billion)

27 Canada: Breast Cancer Management Market, By Application, 2019-2028 (USD Billion)

28 Canada: Breast Cancer Management Market, By Product, 2019-2028 (USD Billion)

29 Canada: Breast Cancer Management Market, By End-User, 2019-2028 (USD Billion)

30 Mexico: Breast Cancer Management Market, By Application, 2019-2028 (USD Billion)

31 Mexico: Breast Cancer Management Market, By Product, 2019-2028 (USD Billion)

32 Mexico: Breast Cancer Management Market, By End-User, 2019-2028 (USD Billion)

33 Europe: Breast Cancer Management Market, By Application, 2019-2028 (USD Billion)

34 Europe: Breast Cancer Management Market, By Product, 2019-2028 (USD Billion)

35 Europe: Breast Cancer Management Market, By End-User, 2019-2028 (USD Billion)

36 Germany: Breast Cancer Management Market, By Application, 2019-2028 (USD Billion)

37 Germany: Breast Cancer Management Market, By Product, 2019-2028 (USD Billion)

38 Germany: Breast Cancer Management Market, By End-User, 2019-2028 (USD Billion)

39 UK: Breast Cancer Management Market, By Application, 2019-2028 (USD Billion)

40 UK: Breast Cancer Management Market, By Product, 2019-2028 (USD Billion)

41 UK: Breast Cancer Management Market, By End-User, 2019-2028 (USD Billion)

42 France: Breast Cancer Management Market, By Application, 2019-2028 (USD Billion)

43 France: Breast Cancer Management Market, By Product, 2019-2028 (USD Billion)

44 France: Breast Cancer Management Market, By End-User, 2019-2028 (USD Billion)

45 Italy: Breast Cancer Management Market, By Application, 2019-2028 (USD Billion)

46 Italy: Breast Cancer Management Market, By T Product Type, 2019-2028 (USD Billion)

47 Italy: Breast Cancer Management Market, By End-User, 2019-2028 (USD Billion)

48 Spain: Breast Cancer Management Market, By Application, 2019-2028 (USD Billion)

49 Spain: Breast Cancer Management Market, By Product, 2019-2028 (USD Billion)

50 Spain: Breast Cancer Management Market, By End-User, 2019-2028 (USD Billion)

51 Rest Of Europe: Breast Cancer Management Market, By Application, 2019-2028 (USD Billion)

52 Rest Of Europe: Breast Cancer Management Market, By Product, 2019-2028 (USD Billion)

53 Rest of Europe: Breast Cancer Management Market, By End-User, 2019-2028 (USD Billion)

54 Asia Pacific: Breast Cancer Management Market, By Application, 2019-2028 (USD Billion)

55 Asia Pacific: Breast Cancer Management Market, By Product, 2019-2028 (USD Billion)

56 Asia Pacific: Breast Cancer Management Market, By End-User, 2019-2028 (USD Billion)

57 Asia Pacific: Breast Cancer Management Market, By Country, 2019-2028 (USD Billion)

58 China: Breast Cancer Management Market, By Application, 2019-2028 (USD Billion)

59 China: Breast Cancer Management Market, By Product, 2019-2028 (USD Billion)

60 China: Breast Cancer Management Market, By End-User, 2019-2028 (USD Billion)

61 India: Breast Cancer Management Market, By Application, 2019-2028 (USD Billion)

62 India: Breast Cancer Management Market, By Product, 2019-2028 (USD Billion)

63 India: Breast Cancer Management Market, By End-User, 2019-2028 (USD Billion)

64 Japan: Breast Cancer Management Market, By Application, 2019-2028 (USD Billion)

65 Japan: Breast Cancer Management Market, By Product, 2019-2028 (USD Billion)

66 Japan: Breast Cancer Management Market, By End-User, 2019-2028 (USD Billion)

67 South Korea: Breast Cancer Management Market, By Application, 2019-2028 (USD Billion)

68 South Korea: Breast Cancer Management Market, By Product, 2019-2028 (USD Billion)

69 South Korea: Breast Cancer Management Market, By End-User, 2019-2028 (USD Billion)

70 Middle East & Africa: Breast Cancer Management Market, By Application, 2019-2028 (USD Billion)

71 Middle East & Africa: Breast Cancer Management Market, By Product, 2019-2028 (USD Billion)

72 Middle East & Africa: Breast Cancer Management Market, By End-User, 2019-2028 (USD Billion)

73 Middle East & Africa: Breast Cancer Management Market, By Country, 2019-2028 (USD Billion)

74 Saudi Arabia: Breast Cancer Management Market, By Application, 2019-2028 (USD Billion)

75 Saudi Arabia: Breast Cancer Management Market, By Product, 2019-2028 (USD Billion)

76 Saudi Arabia: Breast Cancer Management Market, By End-User, 2019-2028 (USD Billion)

77 UAE: Breast Cancer Management Market, By Application, 2019-2028 (USD Billion)

78 UAE: Breast Cancer Management Market, By Product, 2019-2028 (USD Billion)

79 UAE: Breast Cancer Management Market, By End-User, 2019-2028 (USD Billion)

80 Central & South America: Breast Cancer Management Market, By Application, 2019-2028 (USD Billion)

81 Central & South America: Breast Cancer Management Market, By Product, 2019-2028 (USD Billion)

82 Central & South America: Breast Cancer Management Market, By End-User, 2019-2028 (USD Billion)

83 Central & South America: Breast Cancer Management Market, By Country, 2019-2028 (USD Billion)

84 Brazil: Breast Cancer Management Market, By Application, 2019-2028 (USD Billion)

85 Brazil: Breast Cancer Management Market, By Product, 2019-2028 (USD Billion)

86 Brazil: Breast Cancer Management Market, By End-User, 2019-2028 (USD Billion)

87 Hologic Inc.: Products Offered

88 Genomic Health: Products Offered

89 BD Inc.: Products Offered

90 Danaher: Products Offered

91 Koninklijke Philips N.V.: Products Offered

92 F. Hoffmann-La Roche Ltd.: Products Offered

93 Welch Allyn Inc: Products Offered

94 Qiagen: Products Offered

95 Argon Medical Devices: Products Offered

96 Thermo Fisher Scientific: Products Offered

97 Other Companies: Products Offered

List of Figures

1. Global Breast Cancer Management Market Segmentation & Research Scope

2. Primary Research Partners and Local Informers

3. Primary Research Process

4. Primary Research Approaches

5. Primary Research Responses

6. Global Breast Cancer Management Market: Penetration & Growth Prospect Mapping

7. Global Breast Cancer Management Market: Value Chain Analysis

8. Global Breast Cancer Management Market Drivers

9. Global Breast Cancer Management Market Restraints

10. Global Breast Cancer Management Market Opportunities

11. Global Breast Cancer Management Market Challenges

12. Key Breast Cancer Management Market Manufacturer Analysis

13. Global Breast Cancer Management Market: Porter’s Five Forces Analysis

14. PESTLE Analysis & Impact Analysis

15. Hologic Inc.: Company Snapshot

16. Hologic Inc.: SWOT Analysis

17. Genomic Health: Company Snapshot

18. Genomic Health: SWOT Analysis

19. BD Inc.: Company Snapshot

20. BD Inc.: SWOT Analysis

21. Danaher: Company Snapshot

22. Danaher: SWOT Analysis

23. Koninklijke Philips N.V.: Company Snapshot

24. Koninklijke Philips N.V.: SWOT Analysis

25. F. Hoffmann-La Roche Ltd.: Company Snapshot

26. F. Hoffmann-La Roche Ltd.: SWOT Analysis

27. Welch Allyn Inc: Company Snapshot

28. Welch Allyn Inc: SWOT Analysis

29. Qiagen: Company Snapshot

30. Qiagen: SWOT Analysis

31. Argon Medical Devices: Company Snapshot

32. Argon Medical Devices: SWOT Analysis

33. Thermo Fisher Scientific: Company Snapshot

34. Thermo Fisher Scientific: SWOT Analysis

35. Other Companies: Company Snapshot

36. Other Companies: SWOT Analysis

The Global Breast Cancer Management Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Breast Cancer Management Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

What is the projected market size of the Breast Cancer Management market?

The Global Breast Cancer Management Market is projected to grow at a CAGR of 12.1% from 2023 to 2028 and accounted for a market revenue of USD 28.2 billion in 2022.

Who are the major vendors in the Breast Cancer Management market?

The paramount competitors covered in the Breast Cancer Management market report are Hologic Inc., Genomic Health, BD Inc., Danaher, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., Welch Allyn, Qiagen, Argon Medical Devices, and Thermo Fisher Scientific, among others.

What are the opportunities prevailing in the global Breast Cancer Management market?

What are the major drivers in the Breast Cancer Management market?

Breast cancer is one of the most common cancers worldwide and an efficient, accurate treatment and management plan is required to improve the diagnostics and post-care management is extremely crucial. Thus, the occurrence and mortality rate of the disease drives the global breast cancer management market.